nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Tazarotene—psoriasis	0.0734	0.135	CbGbCtD
Mirtazapine—CYP1A2—Clobetasol propionate—psoriasis	0.0697	0.128	CbGbCtD
Mirtazapine—CYP1A2—Methoxsalen—psoriasis	0.0366	0.0674	CbGbCtD
Mirtazapine—CYP2D6—Hydroxyurea—psoriasis	0.033	0.0607	CbGbCtD
Mirtazapine—CYP2C8—Cholecalciferol—psoriasis	0.0313	0.0577	CbGbCtD
Mirtazapine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0272	0.05	CbGbCtD
Mirtazapine—CYP3A4—Calcitriol—psoriasis	0.0247	0.0454	CbGbCtD
Mirtazapine—CYP2C9—Cholecalciferol—psoriasis	0.0218	0.0402	CbGbCtD
Mirtazapine—CYP2C8—Hydrocortisone—psoriasis	0.0218	0.0401	CbGbCtD
Mirtazapine—CYP2C8—Cyclosporine—psoriasis	0.0206	0.0379	CbGbCtD
Mirtazapine—CYP2D6—Cholecalciferol—psoriasis	0.02	0.0368	CbGbCtD
Mirtazapine—CYP3A4—Methoxsalen—psoriasis	0.0192	0.0353	CbGbCtD
Mirtazapine—CYP2C9—Cyclosporine—psoriasis	0.0144	0.0264	CbGbCtD
Mirtazapine—CYP2C8—Dexamethasone—psoriasis	0.0136	0.0249	CbGbCtD
Mirtazapine—CYP2D6—Cyclosporine—psoriasis	0.0131	0.0242	CbGbCtD
Mirtazapine—CYP3A4—Cholecalciferol—psoriasis	0.0127	0.0234	CbGbCtD
Mirtazapine—CYP3A4—Mycophenolate mofetil—psoriasis	0.011	0.0203	CbGbCtD
Mirtazapine—CYP3A4—Triamcinolone—psoriasis	0.011	0.0203	CbGbCtD
Mirtazapine—CYP2C9—Dexamethasone—psoriasis	0.00945	0.0174	CbGbCtD
Mirtazapine—CYP3A4—Betamethasone—psoriasis	0.00945	0.0174	CbGbCtD
Mirtazapine—CYP3A4—Prednisolone—psoriasis	0.00932	0.0172	CbGbCtD
Mirtazapine—CYP3A4—Hydrocortisone—psoriasis	0.00884	0.0163	CbGbCtD
Mirtazapine—CYP3A4—Prednisone—psoriasis	0.0088	0.0162	CbGbCtD
Mirtazapine—CYP2D6—Dexamethasone—psoriasis	0.00864	0.0159	CbGbCtD
Mirtazapine—CYP3A4—Cyclosporine—psoriasis	0.00835	0.0154	CbGbCtD
Mirtazapine—CYP3A4—Dexamethasone—psoriasis	0.0055	0.0101	CbGbCtD
Mirtazapine—Myalgia—Betamethasone—psoriasis	8.48e-05	0.00021	CcSEcCtD
Mirtazapine—Myalgia—Dexamethasone—psoriasis	8.48e-05	0.00021	CcSEcCtD
Mirtazapine—Body temperature increased—Cyclosporine—psoriasis	8.46e-05	0.00021	CcSEcCtD
Mirtazapine—Abdominal pain—Cyclosporine—psoriasis	8.46e-05	0.00021	CcSEcCtD
Mirtazapine—Anxiety—Dexamethasone—psoriasis	8.45e-05	0.00021	CcSEcCtD
Mirtazapine—Anxiety—Betamethasone—psoriasis	8.45e-05	0.00021	CcSEcCtD
Mirtazapine—Vomiting—Mycophenolic acid—psoriasis	8.41e-05	0.000209	CcSEcCtD
Mirtazapine—Discomfort—Betamethasone—psoriasis	8.38e-05	0.000208	CcSEcCtD
Mirtazapine—Discomfort—Dexamethasone—psoriasis	8.38e-05	0.000208	CcSEcCtD
Mirtazapine—Dyspepsia—Hydrocortisone—psoriasis	8.37e-05	0.000208	CcSEcCtD
Mirtazapine—Rash—Mycophenolic acid—psoriasis	8.34e-05	0.000207	CcSEcCtD
Mirtazapine—Dermatitis—Mycophenolic acid—psoriasis	8.34e-05	0.000207	CcSEcCtD
Mirtazapine—Pain—Prednisolone—psoriasis	8.33e-05	0.000207	CcSEcCtD
Mirtazapine—Hepatitis—Methotrexate—psoriasis	8.33e-05	0.000207	CcSEcCtD
Mirtazapine—Urticaria—Mycophenolate mofetil—psoriasis	8.3e-05	0.000206	CcSEcCtD
Mirtazapine—Headache—Mycophenolic acid—psoriasis	8.29e-05	0.000206	CcSEcCtD
Mirtazapine—Decreased appetite—Hydrocortisone—psoriasis	8.27e-05	0.000205	CcSEcCtD
Mirtazapine—Pharyngitis—Methotrexate—psoriasis	8.26e-05	0.000205	CcSEcCtD
Mirtazapine—Abdominal pain—Mycophenolate mofetil—psoriasis	8.25e-05	0.000205	CcSEcCtD
Mirtazapine—Body temperature increased—Mycophenolate mofetil—psoriasis	8.25e-05	0.000205	CcSEcCtD
Mirtazapine—Urinary tract disorder—Methotrexate—psoriasis	8.22e-05	0.000204	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.21e-05	0.000204	CcSEcCtD
Mirtazapine—Fatigue—Hydrocortisone—psoriasis	8.2e-05	0.000203	CcSEcCtD
Mirtazapine—Urethral disorder—Methotrexate—psoriasis	8.16e-05	0.000202	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.16e-05	0.000202	CcSEcCtD
Mirtazapine—Pain—Hydrocortisone—psoriasis	8.14e-05	0.000202	CcSEcCtD
Mirtazapine—Oedema—Dexamethasone—psoriasis	8.13e-05	0.000202	CcSEcCtD
Mirtazapine—Oedema—Betamethasone—psoriasis	8.13e-05	0.000202	CcSEcCtD
Mirtazapine—Insomnia—Triamcinolone—psoriasis	8.1e-05	0.000201	CcSEcCtD
Mirtazapine—Infection—Betamethasone—psoriasis	8.07e-05	0.0002	CcSEcCtD
Mirtazapine—Infection—Dexamethasone—psoriasis	8.07e-05	0.0002	CcSEcCtD
Mirtazapine—Ill-defined disorder—Prednisone—psoriasis	8.05e-05	0.0002	CcSEcCtD
Mirtazapine—Paraesthesia—Triamcinolone—psoriasis	8.04e-05	0.0002	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisolone—psoriasis	8.03e-05	0.000199	CcSEcCtD
Mirtazapine—Anaemia—Prednisone—psoriasis	8.02e-05	0.000199	CcSEcCtD
Mirtazapine—Shock—Dexamethasone—psoriasis	8e-05	0.000198	CcSEcCtD
Mirtazapine—Shock—Betamethasone—psoriasis	8e-05	0.000198	CcSEcCtD
Mirtazapine—Dyspnoea—Triamcinolone—psoriasis	7.99e-05	0.000198	CcSEcCtD
Mirtazapine—Nervous system disorder—Dexamethasone—psoriasis	7.97e-05	0.000198	CcSEcCtD
Mirtazapine—Nervous system disorder—Betamethasone—psoriasis	7.97e-05	0.000198	CcSEcCtD
Mirtazapine—Agitation—Prednisone—psoriasis	7.97e-05	0.000198	CcSEcCtD
Mirtazapine—Thrombocytopenia—Dexamethasone—psoriasis	7.96e-05	0.000197	CcSEcCtD
Mirtazapine—Thrombocytopenia—Betamethasone—psoriasis	7.96e-05	0.000197	CcSEcCtD
Mirtazapine—Tachycardia—Betamethasone—psoriasis	7.93e-05	0.000197	CcSEcCtD
Mirtazapine—Tachycardia—Dexamethasone—psoriasis	7.93e-05	0.000197	CcSEcCtD
Mirtazapine—Hypersensitivity—Cyclosporine—psoriasis	7.89e-05	0.000196	CcSEcCtD
Mirtazapine—Dyspepsia—Triamcinolone—psoriasis	7.89e-05	0.000196	CcSEcCtD
Mirtazapine—Erythema multiforme—Methotrexate—psoriasis	7.87e-05	0.000195	CcSEcCtD
Mirtazapine—Nausea—Mycophenolic acid—psoriasis	7.86e-05	0.000195	CcSEcCtD
Mirtazapine—Hyperhidrosis—Dexamethasone—psoriasis	7.86e-05	0.000195	CcSEcCtD
Mirtazapine—Hyperhidrosis—Betamethasone—psoriasis	7.86e-05	0.000195	CcSEcCtD
Mirtazapine—Feeling abnormal—Hydrocortisone—psoriasis	7.84e-05	0.000194	CcSEcCtD
Mirtazapine—Malaise—Prednisone—psoriasis	7.82e-05	0.000194	CcSEcCtD
Mirtazapine—Vertigo—Prednisone—psoriasis	7.79e-05	0.000193	CcSEcCtD
Mirtazapine—Eye disorder—Methotrexate—psoriasis	7.78e-05	0.000193	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Hydrocortisone—psoriasis	7.78e-05	0.000193	CcSEcCtD
Mirtazapine—Syncope—Prednisone—psoriasis	7.78e-05	0.000193	CcSEcCtD
Mirtazapine—Tinnitus—Methotrexate—psoriasis	7.76e-05	0.000193	CcSEcCtD
Mirtazapine—Anorexia—Betamethasone—psoriasis	7.75e-05	0.000192	CcSEcCtD
Mirtazapine—Anorexia—Dexamethasone—psoriasis	7.75e-05	0.000192	CcSEcCtD
Mirtazapine—Urticaria—Prednisolone—psoriasis	7.74e-05	0.000192	CcSEcCtD
Mirtazapine—Cardiac disorder—Methotrexate—psoriasis	7.73e-05	0.000192	CcSEcCtD
Mirtazapine—Fatigue—Triamcinolone—psoriasis	7.72e-05	0.000192	CcSEcCtD
Mirtazapine—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.69e-05	0.000191	CcSEcCtD
Mirtazapine—Asthenia—Cyclosporine—psoriasis	7.68e-05	0.00019	CcSEcCtD
Mirtazapine—Pain—Triamcinolone—psoriasis	7.66e-05	0.00019	CcSEcCtD
Mirtazapine—Loss of consciousness—Prednisone—psoriasis	7.62e-05	0.000189	CcSEcCtD
Mirtazapine—Hypotension—Betamethasone—psoriasis	7.59e-05	0.000188	CcSEcCtD
Mirtazapine—Hypotension—Dexamethasone—psoriasis	7.59e-05	0.000188	CcSEcCtD
Mirtazapine—Pruritus—Cyclosporine—psoriasis	7.57e-05	0.000188	CcSEcCtD
Mirtazapine—Urticaria—Hydrocortisone—psoriasis	7.56e-05	0.000187	CcSEcCtD
Mirtazapine—Angiopathy—Methotrexate—psoriasis	7.55e-05	0.000187	CcSEcCtD
Mirtazapine—Abdominal pain—Hydrocortisone—psoriasis	7.52e-05	0.000187	CcSEcCtD
Mirtazapine—Body temperature increased—Hydrocortisone—psoriasis	7.52e-05	0.000187	CcSEcCtD
Mirtazapine—Convulsion—Prednisone—psoriasis	7.51e-05	0.000186	CcSEcCtD
Mirtazapine—Asthenia—Mycophenolate mofetil—psoriasis	7.49e-05	0.000186	CcSEcCtD
Mirtazapine—Hypertension—Prednisone—psoriasis	7.49e-05	0.000186	CcSEcCtD
Mirtazapine—Chills—Methotrexate—psoriasis	7.47e-05	0.000185	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.41e-05	0.000184	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Betamethasone—psoriasis	7.41e-05	0.000184	CcSEcCtD
Mirtazapine—Pruritus—Mycophenolate mofetil—psoriasis	7.39e-05	0.000183	CcSEcCtD
Mirtazapine—Arthralgia—Prednisone—psoriasis	7.38e-05	0.000183	CcSEcCtD
Mirtazapine—Myalgia—Prednisone—psoriasis	7.38e-05	0.000183	CcSEcCtD
Mirtazapine—Feeling abnormal—Triamcinolone—psoriasis	7.38e-05	0.000183	CcSEcCtD
Mirtazapine—Anxiety—Prednisone—psoriasis	7.36e-05	0.000183	CcSEcCtD
Mirtazapine—Alopecia—Methotrexate—psoriasis	7.36e-05	0.000182	CcSEcCtD
Mirtazapine—Insomnia—Betamethasone—psoriasis	7.35e-05	0.000182	CcSEcCtD
Mirtazapine—Insomnia—Dexamethasone—psoriasis	7.35e-05	0.000182	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	7.33e-05	0.000182	CcSEcCtD
Mirtazapine—Diarrhoea—Cyclosporine—psoriasis	7.32e-05	0.000182	CcSEcCtD
Mirtazapine—Paraesthesia—Dexamethasone—psoriasis	7.3e-05	0.000181	CcSEcCtD
Mirtazapine—Paraesthesia—Betamethasone—psoriasis	7.3e-05	0.000181	CcSEcCtD
Mirtazapine—Discomfort—Prednisone—psoriasis	7.3e-05	0.000181	CcSEcCtD
Mirtazapine—Mental disorder—Methotrexate—psoriasis	7.29e-05	0.000181	CcSEcCtD
Mirtazapine—Malnutrition—Methotrexate—psoriasis	7.25e-05	0.00018	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisolone—psoriasis	7.18e-05	0.000178	CcSEcCtD
Mirtazapine—Dyspepsia—Dexamethasone—psoriasis	7.15e-05	0.000177	CcSEcCtD
Mirtazapine—Dyspepsia—Betamethasone—psoriasis	7.15e-05	0.000177	CcSEcCtD
Mirtazapine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.14e-05	0.000177	CcSEcCtD
Mirtazapine—Urticaria—Triamcinolone—psoriasis	7.12e-05	0.000177	CcSEcCtD
Mirtazapine—Dysgeusia—Methotrexate—psoriasis	7.1e-05	0.000176	CcSEcCtD
Mirtazapine—Body temperature increased—Triamcinolone—psoriasis	7.08e-05	0.000176	CcSEcCtD
Mirtazapine—Dizziness—Cyclosporine—psoriasis	7.08e-05	0.000176	CcSEcCtD
Mirtazapine—Oedema—Prednisone—psoriasis	7.08e-05	0.000176	CcSEcCtD
Mirtazapine—Decreased appetite—Dexamethasone—psoriasis	7.07e-05	0.000175	CcSEcCtD
Mirtazapine—Decreased appetite—Betamethasone—psoriasis	7.07e-05	0.000175	CcSEcCtD
Mirtazapine—Infection—Prednisone—psoriasis	7.03e-05	0.000174	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.02e-05	0.000174	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Betamethasone—psoriasis	7.02e-05	0.000174	CcSEcCtD
Mirtazapine—Back pain—Methotrexate—psoriasis	7.01e-05	0.000174	CcSEcCtD
Mirtazapine—Hypersensitivity—Hydrocortisone—psoriasis	7.01e-05	0.000174	CcSEcCtD
Mirtazapine—Fatigue—Betamethasone—psoriasis	7.01e-05	0.000174	CcSEcCtD
Mirtazapine—Fatigue—Dexamethasone—psoriasis	7.01e-05	0.000174	CcSEcCtD
Mirtazapine—Shock—Prednisone—psoriasis	6.96e-05	0.000173	CcSEcCtD
Mirtazapine—Pain—Dexamethasone—psoriasis	6.95e-05	0.000172	CcSEcCtD
Mirtazapine—Pain—Betamethasone—psoriasis	6.95e-05	0.000172	CcSEcCtD
Mirtazapine—Nervous system disorder—Prednisone—psoriasis	6.94e-05	0.000172	CcSEcCtD
Mirtazapine—Tachycardia—Prednisone—psoriasis	6.91e-05	0.000171	CcSEcCtD
Mirtazapine—Dizziness—Mycophenolate mofetil—psoriasis	6.91e-05	0.000171	CcSEcCtD
Mirtazapine—Skin disorder—Prednisone—psoriasis	6.88e-05	0.000171	CcSEcCtD
Mirtazapine—Hyperhidrosis—Prednisone—psoriasis	6.84e-05	0.00017	CcSEcCtD
Mirtazapine—Asthenia—Hydrocortisone—psoriasis	6.83e-05	0.000169	CcSEcCtD
Mirtazapine—Vomiting—Cyclosporine—psoriasis	6.81e-05	0.000169	CcSEcCtD
Mirtazapine—Rash—Cyclosporine—psoriasis	6.75e-05	0.000167	CcSEcCtD
Mirtazapine—Anorexia—Prednisone—psoriasis	6.75e-05	0.000167	CcSEcCtD
Mirtazapine—Dermatitis—Cyclosporine—psoriasis	6.74e-05	0.000167	CcSEcCtD
Mirtazapine—Pruritus—Hydrocortisone—psoriasis	6.73e-05	0.000167	CcSEcCtD
Mirtazapine—Ill-defined disorder—Methotrexate—psoriasis	6.73e-05	0.000167	CcSEcCtD
Mirtazapine—Headache—Cyclosporine—psoriasis	6.71e-05	0.000166	CcSEcCtD
Mirtazapine—Anaemia—Methotrexate—psoriasis	6.7e-05	0.000166	CcSEcCtD
Mirtazapine—Feeling abnormal—Dexamethasone—psoriasis	6.7e-05	0.000166	CcSEcCtD
Mirtazapine—Feeling abnormal—Betamethasone—psoriasis	6.7e-05	0.000166	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dexamethasone—psoriasis	6.65e-05	0.000165	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Betamethasone—psoriasis	6.65e-05	0.000165	CcSEcCtD
Mirtazapine—Vomiting—Mycophenolate mofetil—psoriasis	6.64e-05	0.000165	CcSEcCtD
Mirtazapine—Hypersensitivity—Triamcinolone—psoriasis	6.6e-05	0.000164	CcSEcCtD
Mirtazapine—Rash—Mycophenolate mofetil—psoriasis	6.58e-05	0.000163	CcSEcCtD
Mirtazapine—Dermatitis—Mycophenolate mofetil—psoriasis	6.58e-05	0.000163	CcSEcCtD
Mirtazapine—Headache—Mycophenolate mofetil—psoriasis	6.54e-05	0.000162	CcSEcCtD
Mirtazapine—Malaise—Methotrexate—psoriasis	6.54e-05	0.000162	CcSEcCtD
Mirtazapine—Vertigo—Methotrexate—psoriasis	6.51e-05	0.000162	CcSEcCtD
Mirtazapine—Diarrhoea—Hydrocortisone—psoriasis	6.51e-05	0.000161	CcSEcCtD
Mirtazapine—Leukopenia—Methotrexate—psoriasis	6.49e-05	0.000161	CcSEcCtD
Mirtazapine—Urticaria—Betamethasone—psoriasis	6.46e-05	0.00016	CcSEcCtD
Mirtazapine—Urticaria—Dexamethasone—psoriasis	6.46e-05	0.00016	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Prednisone—psoriasis	6.45e-05	0.00016	CcSEcCtD
Mirtazapine—Dizziness—Prednisolone—psoriasis	6.44e-05	0.00016	CcSEcCtD
Mirtazapine—Asthenia—Triamcinolone—psoriasis	6.43e-05	0.000159	CcSEcCtD
Mirtazapine—Body temperature increased—Dexamethasone—psoriasis	6.43e-05	0.000159	CcSEcCtD
Mirtazapine—Abdominal pain—Dexamethasone—psoriasis	6.43e-05	0.000159	CcSEcCtD
Mirtazapine—Abdominal pain—Betamethasone—psoriasis	6.43e-05	0.000159	CcSEcCtD
Mirtazapine—Body temperature increased—Betamethasone—psoriasis	6.43e-05	0.000159	CcSEcCtD
Mirtazapine—Insomnia—Prednisone—psoriasis	6.4e-05	0.000159	CcSEcCtD
Mirtazapine—Nausea—Cyclosporine—psoriasis	6.36e-05	0.000158	CcSEcCtD
Mirtazapine—Paraesthesia—Prednisone—psoriasis	6.36e-05	0.000158	CcSEcCtD
Mirtazapine—Pruritus—Triamcinolone—psoriasis	6.34e-05	0.000157	CcSEcCtD
Mirtazapine—Cough—Methotrexate—psoriasis	6.33e-05	0.000157	CcSEcCtD
Mirtazapine—Dizziness—Hydrocortisone—psoriasis	6.29e-05	0.000156	CcSEcCtD
Mirtazapine—Convulsion—Methotrexate—psoriasis	6.28e-05	0.000156	CcSEcCtD
Mirtazapine—Dyspepsia—Prednisone—psoriasis	6.23e-05	0.000155	CcSEcCtD
Mirtazapine—Nausea—Mycophenolate mofetil—psoriasis	6.2e-05	0.000154	CcSEcCtD
Mirtazapine—Chest pain—Methotrexate—psoriasis	6.17e-05	0.000153	CcSEcCtD
Mirtazapine—Arthralgia—Methotrexate—psoriasis	6.17e-05	0.000153	CcSEcCtD
Mirtazapine—Myalgia—Methotrexate—psoriasis	6.17e-05	0.000153	CcSEcCtD
Mirtazapine—Decreased appetite—Prednisone—psoriasis	6.15e-05	0.000153	CcSEcCtD
Mirtazapine—Rash—Prednisolone—psoriasis	6.14e-05	0.000152	CcSEcCtD
Mirtazapine—Dermatitis—Prednisolone—psoriasis	6.14e-05	0.000152	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.13e-05	0.000152	CcSEcCtD
Mirtazapine—Fatigue—Prednisone—psoriasis	6.1e-05	0.000151	CcSEcCtD
Mirtazapine—Headache—Prednisolone—psoriasis	6.1e-05	0.000151	CcSEcCtD
Mirtazapine—Discomfort—Methotrexate—psoriasis	6.1e-05	0.000151	CcSEcCtD
Mirtazapine—Constipation—Prednisone—psoriasis	6.05e-05	0.00015	CcSEcCtD
Mirtazapine—Vomiting—Hydrocortisone—psoriasis	6.05e-05	0.00015	CcSEcCtD
Mirtazapine—Rash—Hydrocortisone—psoriasis	6e-05	0.000149	CcSEcCtD
Mirtazapine—Dermatitis—Hydrocortisone—psoriasis	5.99e-05	0.000149	CcSEcCtD
Mirtazapine—Confusional state—Methotrexate—psoriasis	5.96e-05	0.000148	CcSEcCtD
Mirtazapine—Headache—Hydrocortisone—psoriasis	5.96e-05	0.000148	CcSEcCtD
Mirtazapine—Dizziness—Triamcinolone—psoriasis	5.92e-05	0.000147	CcSEcCtD
Mirtazapine—Infection—Methotrexate—psoriasis	5.88e-05	0.000146	CcSEcCtD
Mirtazapine—Feeling abnormal—Prednisone—psoriasis	5.83e-05	0.000145	CcSEcCtD
Mirtazapine—Asthenia—Dexamethasone—psoriasis	5.83e-05	0.000145	CcSEcCtD
Mirtazapine—Asthenia—Betamethasone—psoriasis	5.83e-05	0.000145	CcSEcCtD
Mirtazapine—Nervous system disorder—Methotrexate—psoriasis	5.8e-05	0.000144	CcSEcCtD
Mirtazapine—Thrombocytopenia—Methotrexate—psoriasis	5.79e-05	0.000144	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Prednisone—psoriasis	5.79e-05	0.000144	CcSEcCtD
Mirtazapine—Nausea—Prednisolone—psoriasis	5.79e-05	0.000144	CcSEcCtD
Mirtazapine—Pruritus—Dexamethasone—psoriasis	5.75e-05	0.000143	CcSEcCtD
Mirtazapine—Pruritus—Betamethasone—psoriasis	5.75e-05	0.000143	CcSEcCtD
Mirtazapine—Skin disorder—Methotrexate—psoriasis	5.75e-05	0.000143	CcSEcCtD
Mirtazapine—Hyperhidrosis—Methotrexate—psoriasis	5.72e-05	0.000142	CcSEcCtD
Mirtazapine—Vomiting—Triamcinolone—psoriasis	5.7e-05	0.000141	CcSEcCtD
Mirtazapine—Nausea—Hydrocortisone—psoriasis	5.65e-05	0.00014	CcSEcCtD
Mirtazapine—Rash—Triamcinolone—psoriasis	5.65e-05	0.00014	CcSEcCtD
Mirtazapine—Dermatitis—Triamcinolone—psoriasis	5.64e-05	0.00014	CcSEcCtD
Mirtazapine—Anorexia—Methotrexate—psoriasis	5.64e-05	0.00014	CcSEcCtD
Mirtazapine—Urticaria—Prednisone—psoriasis	5.62e-05	0.000139	CcSEcCtD
Mirtazapine—Headache—Triamcinolone—psoriasis	5.61e-05	0.000139	CcSEcCtD
Mirtazapine—Abdominal pain—Prednisone—psoriasis	5.6e-05	0.000139	CcSEcCtD
Mirtazapine—Body temperature increased—Prednisone—psoriasis	5.6e-05	0.000139	CcSEcCtD
Mirtazapine—Diarrhoea—Betamethasone—psoriasis	5.56e-05	0.000138	CcSEcCtD
Mirtazapine—Diarrhoea—Dexamethasone—psoriasis	5.56e-05	0.000138	CcSEcCtD
Mirtazapine—Hypotension—Methotrexate—psoriasis	5.53e-05	0.000137	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.39e-05	0.000134	CcSEcCtD
Mirtazapine—Dizziness—Dexamethasone—psoriasis	5.37e-05	0.000133	CcSEcCtD
Mirtazapine—Dizziness—Betamethasone—psoriasis	5.37e-05	0.000133	CcSEcCtD
Mirtazapine—Insomnia—Methotrexate—psoriasis	5.35e-05	0.000133	CcSEcCtD
Mirtazapine—Nausea—Triamcinolone—psoriasis	5.32e-05	0.000132	CcSEcCtD
Mirtazapine—Paraesthesia—Methotrexate—psoriasis	5.31e-05	0.000132	CcSEcCtD
Mirtazapine—Dyspnoea—Methotrexate—psoriasis	5.27e-05	0.000131	CcSEcCtD
Mirtazapine—Somnolence—Methotrexate—psoriasis	5.26e-05	0.00013	CcSEcCtD
Mirtazapine—Hypersensitivity—Prednisone—psoriasis	5.22e-05	0.000129	CcSEcCtD
Mirtazapine—Dyspepsia—Methotrexate—psoriasis	5.21e-05	0.000129	CcSEcCtD
Mirtazapine—Vomiting—Betamethasone—psoriasis	5.17e-05	0.000128	CcSEcCtD
Mirtazapine—Vomiting—Dexamethasone—psoriasis	5.17e-05	0.000128	CcSEcCtD
Mirtazapine—Decreased appetite—Methotrexate—psoriasis	5.14e-05	0.000128	CcSEcCtD
Mirtazapine—Rash—Betamethasone—psoriasis	5.12e-05	0.000127	CcSEcCtD
Mirtazapine—Rash—Dexamethasone—psoriasis	5.12e-05	0.000127	CcSEcCtD
Mirtazapine—Dermatitis—Dexamethasone—psoriasis	5.12e-05	0.000127	CcSEcCtD
Mirtazapine—Dermatitis—Betamethasone—psoriasis	5.12e-05	0.000127	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Methotrexate—psoriasis	5.11e-05	0.000127	CcSEcCtD
Mirtazapine—Fatigue—Methotrexate—psoriasis	5.1e-05	0.000126	CcSEcCtD
Mirtazapine—Headache—Dexamethasone—psoriasis	5.09e-05	0.000126	CcSEcCtD
Mirtazapine—Headache—Betamethasone—psoriasis	5.09e-05	0.000126	CcSEcCtD
Mirtazapine—Asthenia—Prednisone—psoriasis	5.08e-05	0.000126	CcSEcCtD
Mirtazapine—Pain—Methotrexate—psoriasis	5.06e-05	0.000125	CcSEcCtD
Mirtazapine—Pruritus—Prednisone—psoriasis	5.01e-05	0.000124	CcSEcCtD
Mirtazapine—Feeling abnormal—Methotrexate—psoriasis	4.87e-05	0.000121	CcSEcCtD
Mirtazapine—Diarrhoea—Prednisone—psoriasis	4.84e-05	0.00012	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Methotrexate—psoriasis	4.84e-05	0.00012	CcSEcCtD
Mirtazapine—Nausea—Dexamethasone—psoriasis	4.83e-05	0.00012	CcSEcCtD
Mirtazapine—Nausea—Betamethasone—psoriasis	4.83e-05	0.00012	CcSEcCtD
Mirtazapine—Urticaria—Methotrexate—psoriasis	4.7e-05	0.000117	CcSEcCtD
Mirtazapine—Dizziness—Prednisone—psoriasis	4.68e-05	0.000116	CcSEcCtD
Mirtazapine—Body temperature increased—Methotrexate—psoriasis	4.68e-05	0.000116	CcSEcCtD
Mirtazapine—Abdominal pain—Methotrexate—psoriasis	4.68e-05	0.000116	CcSEcCtD
Mirtazapine—Vomiting—Prednisone—psoriasis	4.5e-05	0.000112	CcSEcCtD
Mirtazapine—Rash—Prednisone—psoriasis	4.46e-05	0.000111	CcSEcCtD
Mirtazapine—Dermatitis—Prednisone—psoriasis	4.46e-05	0.000111	CcSEcCtD
Mirtazapine—Headache—Prednisone—psoriasis	4.43e-05	0.00011	CcSEcCtD
Mirtazapine—Hypersensitivity—Methotrexate—psoriasis	4.36e-05	0.000108	CcSEcCtD
Mirtazapine—Asthenia—Methotrexate—psoriasis	4.24e-05	0.000105	CcSEcCtD
Mirtazapine—Nausea—Prednisone—psoriasis	4.2e-05	0.000104	CcSEcCtD
Mirtazapine—Pruritus—Methotrexate—psoriasis	4.19e-05	0.000104	CcSEcCtD
Mirtazapine—Diarrhoea—Methotrexate—psoriasis	4.05e-05	0.0001	CcSEcCtD
Mirtazapine—Dizziness—Methotrexate—psoriasis	3.91e-05	9.7e-05	CcSEcCtD
Mirtazapine—Vomiting—Methotrexate—psoriasis	3.76e-05	9.33e-05	CcSEcCtD
Mirtazapine—Rash—Methotrexate—psoriasis	3.73e-05	9.25e-05	CcSEcCtD
Mirtazapine—Dermatitis—Methotrexate—psoriasis	3.73e-05	9.24e-05	CcSEcCtD
Mirtazapine—Headache—Methotrexate—psoriasis	3.71e-05	9.19e-05	CcSEcCtD
Mirtazapine—Nausea—Methotrexate—psoriasis	3.51e-05	8.72e-05	CcSEcCtD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.31e-05	0.000244	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SOCS1—psoriasis	1.3e-05	0.000242	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.3e-05	0.000242	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—LEP—psoriasis	1.3e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—APOE—psoriasis	1.3e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SOCS1—psoriasis	1.29e-05	0.000241	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.27e-05	0.000236	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000235	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1.24e-05	0.000232	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.24e-05	0.000231	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—LEP—psoriasis	1.24e-05	0.000231	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—APOE—psoriasis	1.24e-05	0.000231	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—CXCL8—psoriasis	1.24e-05	0.000231	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.23e-05	0.00023	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CARM1—psoriasis	1.23e-05	0.000229	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000229	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CARM1—psoriasis	1.22e-05	0.000227	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	1.22e-05	0.000227	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NFKBIA—psoriasis	1.21e-05	0.000225	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—VEGFA—psoriasis	1.2e-05	0.000224	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000224	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.19e-05	0.000222	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—APOE—psoriasis	1.18e-05	0.000221	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—LEP—psoriasis	1.18e-05	0.000221	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.18e-05	0.00022	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CAT—psoriasis	1.16e-05	0.000216	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.000215	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.000214	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000213	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.14e-05	0.000212	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—CXCL8—psoriasis	1.13e-05	0.00021	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.000209	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.000209	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.12e-05	0.000208	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TP53—psoriasis	1.12e-05	0.000208	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—APOE—psoriasis	1.11e-05	0.000207	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000206	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NFKBIA—psoriasis	1.1e-05	0.000206	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—LEP—psoriasis	1.1e-05	0.000205	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—APOE—psoriasis	1.1e-05	0.000205	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.1e-05	0.000205	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000203	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.08e-05	0.000201	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.07e-05	0.0002	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.0002	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000199	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.05e-05	0.000196	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.000195	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.000195	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CARM1—psoriasis	1.04e-05	0.000194	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000191	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.03e-05	0.000191	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000191	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.02e-05	0.000191	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—psoriasis	1.02e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.01e-05	0.000187	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TYK2—psoriasis	1e-05	0.000187	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—LEP—psoriasis	1e-05	0.000187	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—APOE—psoriasis	1e-05	0.000187	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TYK2—psoriasis	9.89e-06	0.000184	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—APOE—psoriasis	9.82e-06	0.000183	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—LEP—psoriasis	9.82e-06	0.000183	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	9.75e-06	0.000182	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.74e-06	0.000182	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PPARG—psoriasis	9.68e-06	0.00018	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—APOE—psoriasis	9.6e-06	0.000179	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—LEP—psoriasis	9.6e-06	0.000179	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—LEP—psoriasis	9.55e-06	0.000178	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—APOE—psoriasis	9.55e-06	0.000178	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—CXCL8—psoriasis	9.48e-06	0.000177	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TYK2—psoriasis	9.47e-06	0.000176	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NFKBIA—psoriasis	9.35e-06	0.000174	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—psoriasis	9.35e-06	0.000174	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	9.35e-06	0.000174	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	9.33e-06	0.000174	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—CXCL8—psoriasis	9.31e-06	0.000173	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—LEP—psoriasis	9.29e-06	0.000173	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—APOE—psoriasis	9.29e-06	0.000173	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CAT—psoriasis	9.22e-06	0.000172	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NFKBIA—psoriasis	9.15e-06	0.00017	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	9.14e-06	0.00017	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—psoriasis	9.08e-06	0.000169	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TYK2—psoriasis	9.04e-06	0.000168	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—APOE—psoriasis	9.02e-06	0.000168	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	8.95e-06	0.000167	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	8.9e-06	0.000166	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CXCL8—psoriasis	8.75e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	8.66e-06	0.000161	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCL8—psoriasis	8.61e-06	0.00016	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	8.49e-06	0.000158	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—APOE—psoriasis	8.43e-06	0.000157	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—LEP—psoriasis	8.43e-06	0.000157	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TYK2—psoriasis	8.41e-06	0.000157	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—psoriasis	8.32e-06	0.000155	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—LEP—psoriasis	8.29e-06	0.000155	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APOE—psoriasis	8.29e-06	0.000155	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—LEP—psoriasis	8.28e-06	0.000154	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APOE—psoriasis	8.28e-06	0.000154	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCL8—psoriasis	8.24e-06	0.000154	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—psoriasis	8.19e-06	0.000153	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—JUN—psoriasis	8.13e-06	0.000152	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APOE—psoriasis	8.12e-06	0.000151	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—LEP—psoriasis	8.12e-06	0.000151	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CARM1—psoriasis	8.04e-06	0.00015	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—JUN—psoriasis	8e-06	0.000149	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCL8—psoriasis	7.87e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PPARG—psoriasis	7.86e-06	0.000146	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NFKBIA—psoriasis	7.85e-06	0.000146	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—psoriasis	7.84e-06	0.000146	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NFKB1—psoriasis	7.83e-06	0.000146	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	7.73e-06	0.000144	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NFKBIA—psoriasis	7.71e-06	0.000144	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NFKB1—psoriasis	7.7e-06	0.000144	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—JUN—psoriasis	7.66e-06	0.000143	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TYK2—psoriasis	7.66e-06	0.000143	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CAT—psoriasis	7.57e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.57e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APOE—psoriasis	7.55e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—LEP—psoriasis	7.55e-06	0.000141	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CAT—psoriasis	7.5e-06	0.00014	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TYK2—psoriasis	7.49e-06	0.00014	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—psoriasis	7.48e-06	0.000139	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NFKB1—psoriasis	7.38e-06	0.000137	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TYK2—psoriasis	7.33e-06	0.000137	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL8—psoriasis	7.32e-06	0.000136	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—JUN—psoriasis	7.31e-06	0.000136	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TYK2—psoriasis	7.29e-06	0.000136	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—APOE—psoriasis	7.16e-06	0.000133	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—VEGFA—psoriasis	7.1e-06	0.000132	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TYK2—psoriasis	7.09e-06	0.000132	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NFKB1—psoriasis	7.04e-06	0.000131	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STAT3—psoriasis	7.03e-06	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	7.03e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—VEGFA—psoriasis	6.99e-06	0.00013	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—psoriasis	6.96e-06	0.00013	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STAT3—psoriasis	6.92e-06	0.000129	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—JUN—psoriasis	6.81e-06	0.000127	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—psoriasis	6.69e-06	0.000125	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—psoriasis	6.67e-06	0.000124	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—psoriasis	6.63e-06	0.000124	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NFKB1—psoriasis	6.55e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—psoriasis	6.52e-06	0.000122	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TYK2—psoriasis	6.43e-06	0.00012	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAT—psoriasis	6.41e-06	0.000119	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—psoriasis	6.39e-06	0.000119	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—psoriasis	6.38e-06	0.000119	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.35e-06	0.000118	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—psoriasis	6.34e-06	0.000118	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TYK2—psoriasis	6.33e-06	0.000118	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—psoriasis	6.33e-06	0.000118	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TYK2—psoriasis	6.32e-06	0.000118	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—psoriasis	6.24e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—psoriasis	6.2e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—JUN—psoriasis	6.2e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TYK2—psoriasis	6.2e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—psoriasis	6.17e-06	0.000115	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—psoriasis	6.07e-06	0.000113	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—JUN—psoriasis	6.07e-06	0.000113	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—psoriasis	6.04e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NFKB1—psoriasis	5.97e-06	0.000111	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—psoriasis	5.95e-06	0.000111	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—JUN—psoriasis	5.93e-06	0.000111	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—JUN—psoriasis	5.9e-06	0.00011	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—psoriasis	5.89e-06	0.00011	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—psoriasis	5.88e-06	0.00011	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—psoriasis	5.87e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NFKB1—psoriasis	5.84e-06	0.000109	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—psoriasis	5.83e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TYK2—psoriasis	5.76e-06	0.000107	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—JUN—psoriasis	5.74e-06	0.000107	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NFKB1—psoriasis	5.71e-06	0.000106	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.68e-06	0.000106	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—psoriasis	5.6e-06	0.000104	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NFKB1—psoriasis	5.52e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.51e-06	0.000103	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—psoriasis	5.5e-06	0.000102	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—psoriasis	5.42e-06	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.4e-06	0.000101	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—psoriasis	5.37e-06	0.0001	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—psoriasis	5.36e-06	0.0001	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—psoriasis	5.33e-06	9.93e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—psoriasis	5.3e-06	9.87e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—psoriasis	5.28e-06	9.85e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—psoriasis	5.25e-06	9.78e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—psoriasis	5.24e-06	9.77e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—psoriasis	5.23e-06	9.75e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—JUN—psoriasis	5.21e-06	9.7e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.18e-06	9.66e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.16e-06	9.61e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.13e-06	9.56e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—psoriasis	5.13e-06	9.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—JUN—psoriasis	5.12e-06	9.55e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—psoriasis	5.12e-06	9.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—JUN—psoriasis	5.11e-06	9.53e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—psoriasis	5.1e-06	9.51e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—psoriasis	5.08e-06	9.46e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—psoriasis	5.06e-06	9.42e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.02e-06	9.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.01e-06	9.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—psoriasis	5.01e-06	9.34e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NFKB1—psoriasis	5.01e-06	9.34e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—psoriasis	4.98e-06	9.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—psoriasis	4.96e-06	9.25e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—psoriasis	4.95e-06	9.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NFKB1—psoriasis	4.93e-06	9.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NFKB1—psoriasis	4.92e-06	9.17e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—psoriasis	4.91e-06	9.15e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—psoriasis	4.84e-06	9.01e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.83e-06	9e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—psoriasis	4.83e-06	9e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—psoriasis	4.77e-06	8.89e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—JUN—psoriasis	4.66e-06	8.69e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—psoriasis	4.63e-06	8.63e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—psoriasis	4.55e-06	8.48e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—psoriasis	4.5e-06	8.39e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—psoriasis	4.49e-06	8.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	4.49e-06	8.36e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.48e-06	8.34e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—psoriasis	4.47e-06	8.32e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—psoriasis	4.43e-06	8.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—psoriasis	4.42e-06	8.24e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—psoriasis	4.42e-06	8.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.38e-06	8.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.34e-06	8.09e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—psoriasis	4.34e-06	8.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—psoriasis	4.11e-06	7.66e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—psoriasis	4.09e-06	7.63e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.07e-06	7.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.03e-06	7.51e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—psoriasis	4e-06	7.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—psoriasis	3.92e-06	7.3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—psoriasis	3.9e-06	7.26e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—psoriasis	3.84e-06	7.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—psoriasis	3.79e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—psoriasis	3.75e-06	6.98e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—psoriasis	3.67e-06	6.83e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—psoriasis	3.58e-06	6.68e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—psoriasis	3.57e-06	6.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—psoriasis	3.47e-06	6.46e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—psoriasis	3.44e-06	6.41e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—psoriasis	3.38e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—psoriasis	3.38e-06	6.29e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—psoriasis	3.35e-06	6.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.31e-06	6.17e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—psoriasis	3.15e-06	5.86e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—psoriasis	3.1e-06	5.77e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—psoriasis	3.09e-06	5.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.08e-06	5.73e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.03e-06	5.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—psoriasis	2.82e-06	5.25e-05	CbGpPWpGaD
